Publication Name	World Journal of Clinical Cases
Manuscript ID	98769
Country	China

Received	2024-07-05 01:41
Peer-Review Started	2024-07-05 01:41
To Make the First Decision
Return for Revision	2024-11-25 10:31
Revised	2024-12-09 03:59
Second Decision	2025-01-02 02:42
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2025-01-02 08:26
Articles in Press	2025-01-02 08:26
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2025-01-13 01:04
Publish the Manuscript Online	2025-01-15 03:58

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Respiratory System
Manuscript Type	Letter to the Editor
Article Title	Insight into the efficacy and safety of pirfenidone: The treatment of idiopathic pulmonary fibrosis
Manuscript Source	Invited Manuscript
All Author List	Li-Ying Xu, Yi Yu and Lu-Sha Cen
ORCID	Author(s) ORCID Number Li-Ying Xu http://orcid.org/0000-0001-8238-106X Yi Yu http://orcid.org/0009-0000-7849-5128 Lu-Sha Cen http://orcid.org/0000-0001-7223-340X
Funding Agency and Grant Number
Corresponding Author	Lu-Sha Cen, PhD, Department of Ophthalmology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), No. 54 Youdian Road, Hangzhou 310006, Zhejiang Province, China. cenlusa2@sina.com
Key Words	Pirfenidone; Idiopathic pulmonary fibrosis; Route of administration; Diagnose; Early treatment; Alternative formulations
Core Tip	Early intervention is essential for idiopathic pulmonary fibrosis (IPF). Lei et al have shown that timely initiation of pirfenidone treatment in individuals diagnosed with IPF can effectively reduce the occurrence of adverse reactions. Moreover, choosing an appropriate pharmaceutical approach or timing for IPF treatment could be beneficial; however, further evidence is required.
Publish Date	2025-01-15 03:58
Citation	<p>Xu LY, Yu Y, Cen LS. Insight into the efficacy and safety of pirfenidone: The treatment of idiopathic pulmonary fibrosis. <i>World J Clin Cases</i> 2025; 13(14): 98769</p>
URL	https://www.wjgnet.com/2307-8960/full/v13/i14/98769.htm
DOI	https://dx.doi.org/10.12998/wjcc.v13.i14.98769

Full Article (PDF)	WJCC-13-98769-with-cover.pdf
Manuscript File	98769_Auto_Edited_020035.docx
Answering Reviewers	98769-answering-reviewers.pdf
Audio Core Tip	98769-audio.mp3
Conflict-of-Interest Disclosure Form	98769-conflict-of-interest-statement.pdf
Copyright License Agreement	98769-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	98769-non-native-speakers.pdf
Peer-review Report	98769-peer-reviews.pdf
Scientific Misconduct Check	98769-scientific-misconduct-check.png
Scientific Editor Work List	98769-scientific-editor-work-list.pdf
CrossCheck Report	98769-crosscheck-report.pdf